Response to "Late relapse rates in patients with early-stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy". - Burkbauer L; Goldbach M; Pomponio M; Tchou J (Journal of surgical oncology, 2020)